NEW YORK, April 18 – Celera, Clontech Laboratories, and Exelixis have subscribed to BioBase’s Transfac Professional database of transcription factors and regulation, the company said Wednesday.

Under the terms of the agreement, Cognia, the North American distributor of Transfac Professional, will provide it along with Match, a new tool that allows users to locate transcription factor binding sites in sequences.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.